Suppr超能文献

采用琼脂稀释法和微量板 Resazurin assay 对 HRv 进行抗分枝杆菌筛选的药用植物研究。

Antimycobacterial screening of selected medicinal plants against HRv using agar dilution method and the microplate resazurin assay.

机构信息

Department of Pharmacognosy and Phytochemistry, K.B. Institute of Pharmaceutical Education and Research, Gandhinagar, Gujarat, India.

出版信息

Int J Mycobacteriol. 2020 Apr-Jun;9(2):150-155. doi: 10.4103/ijmy.ijmy_60_20.

Abstract

BACKGROUND

Tuberculosis (TB), has been serious disease to the global human population causing millions of deaths worldwide. The recent increase in the number of multi-drug resistant clinical isolates of Mycobacterium tuberculosis has created an urgent need for the discovery and development of new anti-TB drugs. Medicinal plants have had a great influence on the daily lives of people living in developing countries, particularly in India. Medicinal plants were selected, and they were evaluated for its anti-TB activity against the pathogenic strain of M. tuberculosis HRv.

METHODS

Eleven medicinal plants were selected on the basis of its literature survey, and three different extracts were prepared. Antimycobacterial activities were screened using two in vitro assays, namely agar dilution assay and microplate resazurin assay against M. tuberculosis H37Rv at different concentrations of prepared extracts. We analyzed minimal inhibition concentrations and percentage of inhibition of the used strain of Mycobacteria. Isoniazid was used as a standard anti-TB drug.

RESULTS

The results of this study showed that aqueous extracts four selected medicinal plants Ocimum sanctum, Adhatoda vasica, Leptadenia reticulata, and Cocculus hirsutus having minimum inhibitory concentration at 500 μg/ml, 500 μg/ml, 250 μg/ml, and 250 μg/ml, respectively, and O. sanctum (60.24%), A. vasica (62.89%), L. reticulata (74.26%), and C. hirsutus (81.67%) showed significant anti-TB activity against M. tuberculosis.

CONCLUSION

This study helps society to found new anti-TB agents having better anti-TB activity with lesser or no side effects.

摘要

背景

结核病(TB)一直是全球人类的严重疾病,导致全球数百万人死亡。最近,耐多药临床分离株结核分枝杆菌数量的增加,迫切需要发现和开发新的抗结核药物。药用植物对发展中国家人民的日常生活产生了巨大影响,尤其是在印度。选择药用植物,并评估其对致病性结核分枝杆菌 HRv 的抗结核活性。

方法

根据文献调查选择了 11 种药用植物,并制备了三种不同的提取物。使用琼脂稀释法和微孔板 Resazurin 法,在不同浓度的提取物下,对 M. tuberculosis H37Rv 进行了两种体外抗结核活性筛选。分析了所用分枝杆菌菌株的最小抑制浓度和抑制百分率。异烟肼用作标准抗结核药物。

结果

本研究结果表明,四种选定药用植物的水提取物 Ocimum sanctum、Adhatoda vasica、Leptadenia reticulata 和 Cocculus hirsutus 的最小抑菌浓度分别为 500μg/ml、500μg/ml、250μg/ml 和 250μg/ml,而 O. sanctum(60.24%)、A. vasica(62.89%)、L. reticulata(74.26%)和 C. hirsutus(81.67%)对结核分枝杆菌具有显著的抗结核活性。

结论

本研究有助于社会发现具有更好抗结核活性、更少或无副作用的新型抗结核药物。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验